Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis rats-Reference-Cited by-同舟云学术

Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis rats

Published:2002-07 Issue:1-2 Volume:16 Page:29-36
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Achira Meguru,Totsuka Ryuichi,Fujimura Hisako,Kume Toshiyuki

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues;Álvarez-Cedrón;J. Chromatogr.,1999

2. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol and antipyrine in the rat;Belpaire;Fundam. Clin. Pharmacol.,1989

3. Plasma propranolol concentrations in rats with adjuvant-induced arthritis;Bishop;Biopharm. Drug Dispos.,1981

4. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver;Booth;Cancer Res.,1998

5. Combined activity of interleukin-1alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects;Borsellino;Anticancer Res.,1994

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases;Molecular and Cellular Biochemistry;2022-01-16

2. Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition;Pharmaceutics;2021-09-23

3. The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases;Biomedicine & Pharmacotherapy;2018-09

4. The absorption enhancement of norisoboldine in the duodenum of adjuvant-induced arthritis rats involves the impairment of P-glycoprotein;Biopharmaceutics & Drug Disposition;2017-01

5. Regulation of Drug Transporters by Inflammation;Drug Metabolism in Diseases;2017